Intimation of closure of trading window for the fourth quarter and financial year 2025-26 ended on 31 March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sampre Nutritions Limited has informed the BSE that its trading window for dealing in company securities will be closed from 1 April 2026 until 48 hours after the declaration of audited financial results (standalone and consolidated) for Q4 and FY 2025-26 ending 31 March 2026. During this period, promoters, directors, designated persons, and their immediate relatives are prohibited from trading in the company's shares. The filing is made under Regulation 9 of SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve the financial results will be communicated separately. The intimation is signed by Managing Director Brahma Gurbani.
This is a routine regulatory compliance filing with no direct impact on the stock price. It indicates that the company's annual financial results are expected soon, and insiders will be barred from trading until those results are publicly disclosed.